CTOs on the Move

Comprehensive Clinical Development

www.comprehensivecd.com

 
Comprehensive Clinical Development is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Destination Pet

Welcome to your destination. Our mission is simple: to provide the best for your pet.

Tahoe Forest Hospital

Proudly serving the community since 1952, Tahoe Forest Hospital is a not for profit rural health care facility and designated Critical Access Hospital. It is fully accredited by the Healthcare Facilities Accreditation Program and licensed by the State of California Department of Health Services. Tahoe Forest Hospital has 25 acute care beds and 36 long-term care beds. Our geographic area covers six rural counties, two states and approximately 3,500 square miles with primary services reaching the communities of Truckee, North Lake Tahoe, Donner Summit and the Sierra Valley in California and Incline Village in Nevada. Tahoe Forest Hospital serves a full-time population of approximately 40,000 residents with influxes of up to an additional 30,000 tourists during peak periods.

Integrity Digital Solutions

Integrity Digital Solutions is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Temple, TX. To find more information about Integrity Digital Solutions, please visit www.integrityemr.com

BaySport

"With corporate headquarters in Los Gatos, BaySport, Inc. has been serving the Bay Area since 1984. The organization has evolved from providing ""on-site"" physical examination programs for corporations, to developing sports medicine centers with a strong"

Stilla Technologies

Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.